Dmitry Balyasny’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-380,000
Closed -$21.5M 2779
2022
Q1
$21.5M Buy
+380,000
New +$20.4M 0.07% 391
2020
Q1
Sell
-300,000
Closed -$15.2M 1186
2019
Q4
$15.2M Buy
+300,000
New +$15.5M 0.09% 322

Other funds holding CAH

Dmitry Balyasny's CAH Position: Q2 2026 in Review

Dmitry Balyasny reduced its Cardinal Health (CAH) stake by 3.5% in Q2 2026, selling an estimated $1.03M and leaving 138,588 shares worth $32.9M. The position accounts for 0.04% of the portfolio, ranked #505.

Dmitry Balyasny first reported a position in CAH in Q2 2013 and has held it in 38 quarters since. The position peaked at $110M in Q1 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Dmitry Balyasny held 138,588 shares of Cardinal Health worth $32.9M as of Q2 2026.
  • Dmitry Balyasny sold 4,972 Cardinal Health shares in Q2 2026, an estimated $1.03M.
  • Cardinal Health made up 0.04% of Dmitry Balyasny's portfolio in Q2 2026, its #505 holding.
  • Dmitry Balyasny first reported a position in Cardinal Health in Q2 2013 and has held it in 38 quarters since.
  • Dmitry Balyasny's Cardinal Health position peaked at $110M in Q1 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.